Jeffrey Hubbell, Eugene Bell Professor in Tissue Engineering at the University of Chicago’s Pritzker School of Molecular Engineering, has been elected to the National Academy of Sciences (NAS) for his distinguished and continuing achievements in bioengineering and immunotherapy.
Hubbell is the only University of Chicago faculty member to be elected to all three National Academies: the National Academy of Sciences, the National Academy of Engineering, and the National Academy of Medicine.
The Academies recognize distinguished scholars and researchers for significant achievements in their fields and advise the federal government and other organizations about science, engineering, and health policy.
An international leader in bioengineering, Hubbell develops molecular and materials engineering approaches to advance immunotherapy. His research is focused on vaccination in infectious disease, cancer, and autoimmune disease. Hubbell designs materials that stimulate the immune system to fight infection or malignancy according to design, disabling certain aspects of the immune response to address auto-immune diseases such as multiple sclerosis or celiac disease. He coined the term “immuno-modulatory materials” to describe this newly emerging field of research. Along with his research associates, he holds more than 100 patents and has founded five companies.
Hubbell also is a member of the National Academy of Inventors.
With Hubbell’s election, Pritzker Molecular Engineering now has seven NAS members on its faculty.